BNM-62681-22129
2 vaccinations
5 coded responses
16 check-ins
5 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 809 / CO
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
- 2020-12-19
- 2020-12-20
-
2020-12-21
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: FairFree text: LightheadedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-22
- 2020-12-27
- 2021-01-03
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-08
-
2021-01-09
Survey response — days 1–6 daily, dose 2MedDRA: Night sweats — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Night sweatsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-11
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain — Feeling: Fair · Site: Pain · Be unable to do your normal daily activitiesFree text: Axillary lymphatic painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-17
- 2021-01-29
- 2021-02-05
-
2021-02-12
Survey response — day 35, dose 2MedDRA: Headache, Nausea, Vomiting — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Nausea, vomiting, HeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Report sent to call center — day 35, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-21
Survey response — day 42, dose 2MedDRA: Nausea, Office visit, Vomiting — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Vomiting and nausea · Healthcare visit (other): Routine appointmentMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-21
Report sent to call center — day 42, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-11
- 2021-05-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech |
Call center
4 call center cases
2 unsuccessful · 2 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Lightheaded
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Night sweats
Systemic reaction (other): Axillary lymphatic pain
Release 4 — day 35, dose 2
Symptoms: Nausea, vomiting, Headache
Release 4 — day 42, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Night sweats | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release